Whitehawk Therapeutics, Inc. (NASDAQ:WHWK – Get Free Report) CEO David James Lennon sold 63,945 shares of the firm’s stock in a transaction dated Wednesday, April 8th. The shares were sold at an average price of $3.40, for a total value of $217,413.00. Following the sale, the chief executive officer owned 533,122 shares in the company, […]

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK – Get Free Report) CEO David James Lennon sold 102,395 shares of Whitehawk Therapeutics stock in a transaction that occurred on Monday, April 6th. The shares were sold at an average price of $3.51, for a total transaction of $359,406.45. Following the sale, the chief executive officer owned 691,154 shares of […]

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK – Get Free Report) CEO David James Lennon sold 26,858 shares of the business’s stock in a transaction dated Thursday, April 2nd. The stock was sold at an average price of $3.48, for a total transaction of $93,465.84. Following the completion of the sale, the chief executive officer owned 793,549 shares […]

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK – Get Free Report) CEO David James Lennon sold 26,858 shares of the firm’s stock in a transaction on Thursday, April 2nd. The stock was sold at an average price of $3.48, for a total value of $93,465.84. Following the completion of the sale, the chief executive officer directly owned 793,549 […]